Metropolitan Life Insurance Company (MetLife)’s Accolade, Inc. Common Stock ACCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,524
Closed -$36.9K 2206
2024
Q1
$36.9K Sell
3,524
-435
-11% -$4.56K ﹤0.01% 1556
2023
Q4
$47.5K Hold
3,959
﹤0.01% 1476
2023
Q3
$41.9K Buy
3,959
+301
+8% +$3.19K ﹤0.01% 1506
2023
Q2
$49.3K Hold
3,658
﹤0.01% 1423
2023
Q1
$52.6K Sell
3,658
-268
-7% -$3.85K ﹤0.01% 1359
2022
Q4
$30.6K Hold
3,926
﹤0.01% 1781
2022
Q3
$44.8K Buy
3,926
+644
+20% +$7.35K ﹤0.01% 1535
2022
Q2
$24.3K Hold
3,282
﹤0.01% 1949
2022
Q1
$57.6K Sell
3,282
-10,627
-76% -$187K ﹤0.01% 1521
2021
Q4
$367K Hold
13,909
0.01% 1616
2021
Q3
$587K Hold
13,909
0.01% 1352
2021
Q2
$755K Buy
13,909
+4,879
+54% +$265K 0.01% 1225
2021
Q1
$410K Buy
9,030
+5,392
+148% +$245K 0.01% 1536
2020
Q4
$158K Hold
3,638
﹤0.01% 2100
2020
Q3
$141K Buy
+3,638
New +$141K ﹤0.01% 2009